Background rate of low‐level HCV RNA in anti‐HCV confirmed‐positive and minipool nucleic acid test‐nonreactive blood donations-Reference-Cited by-同舟云学术

Background rate of low‐level HCV RNA in anti‐HCV confirmed‐positive and minipool nucleic acid test‐nonreactive blood donations

Published:2021-12-09 Issue:1 Volume:62 Page:143-150
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Groves Jamel A.¹,Y. Dodd Roger¹,Zhu Xiaomei²,Linnen Jeffrey M.³,Stramer Susan L.¹^ORCID

Affiliation:

1. Scientific Affairs American Red Cross Gaithersburg Maryland USA

2. Grifols Diagnostic Solutions Emeryville Inc. Emeryville California USA

3. Grifols Diagnostic Solutions Inc. San Diego California USA

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.16759

Reference9 articles.

1. Food and Drug Administration.Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus.2019[cited 2020 Apr 13]. Available from:https://www.fda.gov/media/116353/download.

2. Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations

3. HIV, HCV, and HBV incidence and residual risk in US blood donors before and after implementation of the 12‐month deferral policy for men who have sex with men

4. Grifols Diagnostic Solutions Incorporated.Procleix Ultrio Elite Assay Package Insert: GDSS‐IFU‐000006 v. 4.0(Accessed May 2021).

5. Integration of nucleic acid amplification test results into hepatitis C virus supplemental serologic testing algorithms: implications for donor counseling and revision of existing algorithms

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second hepatitis C virus transmission by blood components since introduction of mandatory NAT screening in Germany;Transfusion;2022-12-14

2. Improved detection of hepatitis C virus‐positive blood donors and determination of infection status;Transfusion Medicine;2022-10-17